PressApril 24, 2026 FDA grants Compass rolling NDA review and a National Priority Voucher for COMP360
PressApril 23, 2026 Psyence doses first patient in Phase 2b psilocybin trial for cancer-related adjustment disorder
PressApril 20, 2026 Helus Pharma CEO Michael Cola steps down; co-founder Eric So returns as interim CEO
